These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 26074082)
1. Programming Hippocampal Neural Stem/Progenitor Cells into Oligodendrocytes Enhances Remyelination in the Adult Brain after Injury. Braun SM; Pilz GA; Machado RA; Moss J; Becher B; Toni N; Jessberger S Cell Rep; 2015 Jun; 11(11):1679-85. PubMed ID: 26074082 [TBL] [Abstract][Full Text] [Related]
2. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination. Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492 [TBL] [Abstract][Full Text] [Related]
3. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum. Guglielmetti C; Praet J; Rangarajan JR; Vreys R; De Vocht N; Maes F; Verhoye M; Ponsaerts P; Van der Linden A Neuroimage; 2014 Feb; 86():99-110. PubMed ID: 23933305 [TBL] [Abstract][Full Text] [Related]
4. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis. Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T Cells; 2019 Sep; 8(9):. PubMed ID: 31484369 [TBL] [Abstract][Full Text] [Related]
6. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638 [TBL] [Abstract][Full Text] [Related]
7. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253 [TBL] [Abstract][Full Text] [Related]
8. Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse. Shimizu T; Tanaka KF; Takebayashi H; Higashi M; Wisesmith W; Ono K; Hitoshi S; Ikenaka K J Neurosci Res; 2013 Feb; 91(2):178-86. PubMed ID: 23172790 [TBL] [Abstract][Full Text] [Related]
10. Invivo insulin deficiency as a potential etiology for demyelinating disease. Gong X; Xie Z; Zuo H Med Hypotheses; 2008 Sep; 71(3):399-403. PubMed ID: 18621485 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor NRF2 controls the fate of neural stem cells in the subgranular zone of the hippocampus. Robledinos-Antón N; Rojo AI; Ferreiro E; Núñez Á; Krause KH; Jaquet V; Cuadrado A Redox Biol; 2017 Oct; 13():393-401. PubMed ID: 28667908 [TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination. Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782 [TBL] [Abstract][Full Text] [Related]